Indications and Purposes
| 1 Indications And Usage Votrient ® Is Indicated For The Treatment Of Patients With Advanced Renal Cell Carcinoma (Rcc). Votrient Is Indicated For The Treatment Of Patients With Advanced Soft Tissue Sarcoma (Sts) Who Have Received Prior Chemotherapy. Limitations Of Use : The Efficacy Of Votrient For The Treatment Of Patients With Adipocytic Sts Or Gastrointestinal Stromal Tumors Has Not Been Demonstrated. Votrient Is A Kinase Inhibitor Indicated For The Treatment Of Patients With: Advanced Renal Cell Carcinoma (Rcc). ( 1 ) Advanced Soft Tissue Sarcoma (Sts) Who Have Received Prior Chemotherapy. ( 1 ) Limitation S Of Use : The Efficacy Of Votrient For The Treatment Of Patients With Adipocytic Soft Tissue Sarcoma Or Gastrointestinal Stromal Tumors Has Not Been Demonstrated. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Pazopanib Hydrochloride |
|
ZINC11617039 |